A Phase 3 Study to Evaluate the Safety and Efficacy of Tc-MIP-1404 SPECT/CT Imaging to Detect Clinically Significant Prostate Cancer in Men with Biopsy Proven Low-Grade Prostate Cancer who are Candidates for Active Surveillance(proSPECT-AS)
Clinical Trial Grant
Administered By
Urology
Awarded By
Molecular Insight Pharmaceuticals, Inc.
Start Date
July 1, 2016
End Date
April 11, 2019
Administered By
Urology
Awarded By
Molecular Insight Pharmaceuticals, Inc.
Start Date
July 1, 2016
End Date
April 11, 2019